The group's principle activity is to engage in distribution and supply of plasma products, diagnostic reagents, automated analyzers, and dosing machines for diagnostic use in laboratories. The group provides plasma-derived clotting factors for the treatment of coagulation disorders, intravenous immunoglobulin for the treatment of immune deficiency disorders, and albumin for volume expansion or replacement. The group operates from United States.
